HOME
Universal Biotech Innovation Grant
Universal Biotech is launching the Innovation Grant in the aim of making it a major event on the European biotechnology scene.
The Universal Biotech Innovation Grant encourages innovative talent and the development of new processes or products in the biotechnology industries sector.
The Award Ceremony will be held during EuroBiO 2009.
PRINCIPLES
The Universal Biotech Innovation Grant will be based on three objectives:
- Innovation – a level of innovation or ingenuity shown in the reflexes and experimentation needed to discover, create or design new applications in the biotechnology industry
- Uniqueness and originality – degree of originality and the design or style used to achieve the invention
- Strategy – sales and marketing plan, market position, product or technology maturity
THEMES
The emphasis for the 2009 Universal Biotech Innovation Grant will be placed on therapeutic innovation. The applications must be entered under one of the two following thematic areas:
Therapy targeted
- Cancer
- Infectiology
- Orphan diseases
Diagnostic products
- Biomarkers (in vivo, in vitro)
CRITERIA OF EVALUATION
• The participants must be :
- A French or European Young Innovative Company
- A French or European research team member
- Individual
• The innovations will be evaluated in accordance to the following criteria :
- Scientific quality of the innovation
- Project progress stage
- Intellectual and industrial property
- Medical need and positionning
- Resources quality
- Success chances
JURY
For 2009, the jury will be under the adjudication of Jean Derégnaucourt, director of the biotechnology department and of the technology management department of the French Ministry of Research.
The jury will be made up of members of well-known French and European institutions :
Gilles BLOCH - General Director at the Research and Innovation Department, Ministry of Higher Level Education and Research
Patrick CHAUSSEPIED - Biology and Health department manager, ANR
Jean DEREGNAUCOURT – Innovation Grant Jury President
Véronique DUFEY – Evaluation Director at Ifremer
Jacques GRASSI – Director of the “ Technologies for Health" Institute
Jean Marc GROGNET –Deputy Director at DGE : "Industries and Technologies of the Living, Chemistry, and Materials" – Scientific Director of the Technological Research Office– CEA
Stéphane HOGAN (MSc, MBA) – Head of Coordination Unit, Directorate Health research, DG Research, European Commission.
Olivier LALAUDE – Medical Director, Laboratoires MSD-Chibret
Pierre Noël LIRSAC – President of Adebiotech - Deputy Director of the "Technologies pour la Santé" program (CEA)
Rafi MARDACHTI – CEO of Universal Medica Group
Pierre TAMBOURIN – Director of Genopole
Etienne VERVAECKE – General Director of Eurasanté
GRANT
A Grant up to 100 000 euros will be shared by two or three winners.
These grants will be awarded after a selection process and a critical evaluation of the candidates applications by an expert jury.
Universal Biotech will assist the winners through their development with certain special privileges and assistance.
